XML 40 R30.htm IDEA: XBRL DOCUMENT v3.20.2
Business Combination (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Aug. 21, 2020
Mar. 03, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Sep. 30, 2020
Sep. 30, 2019
Aug. 18, 2020
Dec. 31, 2019
Common stock, par value     $ 0.02           $ 0.02     $ .02
Debt instrument interest rate percentage     1.00%           1.00%      
Debt principal amount     $ 834,000           $ 834,000     $ 200,000
Warrant exercise price per share     $ 0.029   $ 0.029       $ 0.029      
Non-controlling interest     $ (307,000)           $ (307,000)    
Issuance of common stock, net, shares                    
Issuance of common stock, net     $ 13,088,000 $ 6,185,000 $ 4,054,000 $ 162,000 $ 4,887,000 $ 638,000        
Impact BioMedical, Inc. [Member] | Series A Convertible Preferred Stock [Member]                        
Equity ownership percentage                     19.99%  
Public Offering [Member]                        
Initial public offering percentage     50.00%           50.00%      
Public Offering [Member] | Maximum [Member]                        
Shares issued price per share     $ 10.00           $ 10.00      
AMRE Asset Management Inc. [Member]                        
Equity ownership percentage   52.50%                    
Incurred cost                 $ 595,000      
Non-controlling interest     $ 307,000           $ 307,000      
American Medical Reit Inc. [Member]                        
Equity ownership percentage   93.00%                    
Singapore eDevelopment Limited [Member]                        
Equity ownership percentage   82.00%                    
Term Sheet [Member] | LiquidValue Asset Management Pte Ltd [Member]                        
Equity ownership percentage   35.00%                    
Term Sheet [Member] | AMRE Tennessee, LLC [Member]                        
Equity ownership percentage   12.50%                    
Term Sheet [Member] | American Medical Reit Inc. [Member]                        
Debt instrument interest rate percentage   8.00%                    
Debt maturity date   Mar. 03, 2022                    
Debt principal amount   $ 800,000                    
Number of warrant to purchase shares of common stock   160,000                    
Warrant exercise price per share   $ 5.00                    
Warrant expiration date   Mar. 03, 2024                    
Term Sheet [Member] | AMRE Asset Management Inc. [Member]                        
Number of ordinary shares subscribed   5,250                    
Common stock, par value   $ 0.01                    
Value of ordinary shares subscribed   $ 53                    
Equity ownership percentage   52.50%                    
Term Sheet [Member] | AMRE Asset Management Inc. [Member] | LiquidValue Asset Management Pte Ltd [Member]                        
Number of common stock shares issues   2,500                    
Term Sheet [Member] | AMRE Asset Management Inc. [Member] | AMRE Tennessee, LLC [Member]                        
Number of common stock shares issues   1,250                    
Share Exchange Agreement [Member] | Impact BioMedical, Inc. [Member]                        
Common stock, par value $ 0.02                      
Number of common stock shares issues 483,334                      
Equity ownership percentage 100.00%                      
Shares issued price per share $ 6.48                      
Share Exchange Agreement [Member] | Impact BioMedical, Inc. [Member] | Series A Convertible Preferred Stock [Member]                        
Shares issued price per share $ 1,000                      
Issuance of common stock, net, shares 46,868                      
Issuance of common stock, net $ 46,868,000                      
Consideration value 50,000,000                      
Back-Solve [Member] | Impact BioMedical, Inc. [Member] | Series A Convertible Preferred Stock [Member]                        
Issuance of common stock, net 35,187,000                      
Consideration value $ 38,319,000